He just stated some of his key views. Yes it is a well run business and in good shape. They have been addressing their technical debt as clearly articulated some time back by the new CEO (as do all fast growing and rapidly developing tech startups at some point) in order to facilitate the next step change in their growth plans. This is now mostly complete is my understanding and now the execution and implementation of their reimagine strategy is coming together. It’s is not just a good story - it is a solid and well run business, no secret sauce on this one.
- Forums
- ASX - By Stock
- CL1
- breakout
breakout, page-23
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CL1 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online